Otoimmün Bazal Gangliyon Hastalıkları
Özet
Bazal gangliyonlar, hareket kontrolü ve bilişsel süreçlerde kritik rol oynayan derin beyin yapılarından oluşur ve bu bölgelerin otoimmün süreçlerle etkilenmesi, hareket bozuklukları ile nöropsikiyatrik tablolara neden olur. Sydenham koresi, PANDAS ve anti-NMDA reseptör ensefaliti gibi hastalıklar, antikor aracılı mekanizmalarla bu yapıları hedef alarak distoni, kore ve davranış değişiklikleri gibi klinik tablolara yol açmaktadır. Tanı genellikle klinik şüphe ile konulurken, tedavi süreçlerinde immünmodülatör yaklaşımlar ve altta yatan enfeksiyonların kontrolü temel stratejiyi oluşturur. Erken teşhis ve yönetimin, kalıcı nörolojik hasarı önlemek adına kritik öneme sahip olduğu bu hastalıklar, çok disiplinli bir yaklaşımı gerektirmektedir.
The basal ganglia, essential for motor control and cognitive functions, are susceptible to autoimmune conditions that disrupt normal neural signaling, leading to complex movement disorders and neuropsychiatric symptoms. Conditions such as Sydenham chorea, PANDAS, and anti-NMDA receptor encephalitis result from antibody-mediated mechanisms affecting these deep brain structures, presenting clinically with manifestations like chorea, dystonia, and behavioral changes. Clinical diagnosis relies heavily on recognizing these distinct patterns, while management strategies focus on immunomodulatory treatments and the identification of underlying infectious or paraneoplastic triggers. Prompt therapeutic intervention remains vital in these disorders to mitigate the risk of permanent neurological impairment and ensure better long-term outcomes.
Referanslar
Mendoza, John & Foundas, Anne. (2008). Clinical Neuroanatomy: A Neurobehavioral Approach. 10.1007/978-0-387-36601-2. p.154-155.
Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117(pt 4):859-876.
Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res. 2002; 53(2):647-654.
Erer Özbek S. Otoimmün Nörolojik Hastalıkların Neden Olduğu Hareket Bozuklukları. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2010; 36(3): 127-133.
Gibson DS, Banha J, Penque D, Costa L, Conrads TP, Cahill DJ, O'Brien JK, Rooney ME. Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders. J Proteomics. 2010; 18;73(6):1045-60.
Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell. 2007;130(1):25-35.
Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia. 2001;36(2):118-124.
Dale RC, Brilot F. Autoimmune basal ganglia disorders. J Child Neurol. 2012 Nov;27(11):1470-81. doi: 10.1177/0883073812451327. Epub 2012 Jul 25. PMID: 22832771.
Neuwelt EA, Bauer B, Fahlke C, et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci. 2011;12(3):169-182.
Garvey MA, Perlmutter SJ, Allen AJ, Hamburger S, Lougee L, Leonard HL, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999;45:1564–71.
Swaiman, K.F. & Ashwal, S. & Ferriero, Donna & Schor, Nina & Finkel, R.S. & Gropman, Andrea & Pearl, Phillip & Shevell, M.I. Swaiman's Pediatric Neurology: Principles and Practice: Sixth Edition. 2017; p.708-709.
Church AJ, Cardoso F, Dale RC. Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology 2002; 59:227.
Gerber MA. Rheumatic Fever: In Klıegman, Behrman, Jenson, Stanton Eds. Nelson Textbook of Pediatrics, 18th edition. Saunders Elsevier Philedelphia 2008:1140-5.
Weiner SG, Normandin RN. Sydenham chorea: A case report and review of the literature. Pediatr Emerg Care 2007;23(1):20-4.
Teixera AL, Maia DP, Cardoso F. UFMG Sydenham’s chorea rating scale: Reliability and Consistency. Mov Disord 2005;20(8):585-91.
Demirören K, Oran B. Sydenham Koresi. Genel Tıp Derg 2002;12(2):81-7.
Fahn S. Sydenham chorea: In Rowland LP, Ed. Merritt’s Textbook of Neurology, 11th edition. Lippincott Williams&Wilkins 2008:807-9.
Elibol B. Pathophysiology of pediatric movement disorders. Sydenham koresi. Turkiye Klinikleri J Pediatr Sci 2006;2(8);10-1.
Teixera AL, Bretas TL, Kummer A, Melo LC, Baraldi A, Harsányi E, et al. Serum levels of brainderived neurotrophic factor in Sydenham’s chorea. Neurol Sci 2010 Jun;31(3):399-401.
Menkes JH. Rheumatic fever (Sydenham chorea) In: Child Neurology, Menkes JH, Sarnat HB Eds.6th edition. Lippincott, Williams&Wilkins Philadelphia 2000:652-7.
Gilroy J. Movement Disorders In: Basic Neurology, 3rd edition. Mc Graw‐Hill Newyork 2000:149-52.
Menkes JH. Autoimmune and postinfectious diseases: Rheumatic fever (Sydenham’s In: Textbook of Child Neurology, Menkes JH Ed, 3rd Edition. Lea&Febiger Philadelphia 1985;436-40.
F. Cardoso, Autoimmune choreas, J. Neurol. Neurosurg. Psychiatry 88 (5) (2017) 412–417.
M.W. Cunningham, Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection, Int. Rev. Immunol. 33 (2014) 314–329.
Baizabal-Carvallo JF, Jankovic J. Autoimmune and paraneoplastic movement disorders: An update. J Neurol Sci. 2018 Feb 15;385:175-184. doi: 10.1016/j.jns.2017.12.035. Epub 2017 Dec 30. PMID: 29406902.
Ho L. Hypermetabolism in bilateral basal ganglia in Sydenham chorea on F-18 FDG PET-CT. Clin Nucl Med 2009;34(2):114-6.
Çıtak EÇ, Gücüyener K, Karabacak NI, Serdaroğlu A, Okuyaz Ç, Aydın K. Functional brain imaging in Sydenham’s chorea and streptococal tic disorders. J Child Neurol 2004;19(5):387-90.
Swedo SE, Leonard HL, Schapiro MB. Sydenham’s chorea: Physical and psyhological symptoms of St. Vitus dance. Pediatrics 1993;91(4):706-13.
Mark MH. Other choreatic disorders In: Movement Disorders. Watts RL, Koller WC Eds. Mc Graw Hill Newyork 1997:527-39.
Gümüş, M. Kliniğimizde 2003‐2009 Yılları Arasında Sydenham Kore Tanısı Almış Olguların Geriye Dönük Değerlendirilmesi. Selçuk Üniversitesi Meram Tıp Fakültesi Çocuk Sağlığı Ve Hastalıkları Anabilim Dalı (Uzmanlık Tezi) 2010
Gerber, M.A., Baltimore, R.S., Eaton, C.B., et al., 2009. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: A scientifc statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 119 (11), 1541–1551.
Pina-Garza JE. Movement disorders. In: Pina-Garza, editor. Fenichels clinical pediatric neurology. Seventh ed. Elsevier Saunders, 2013:277-294.
Gordon N. Sydenham’s chorea, and its complications affecting the nervous system. Brain Dev 2009;31:11-14.
Korn-Lubetzki I, Brabd A, Steiner I. Recurrence of Sydenham chorea: implications for pathogenesis. Arch Neurol 2004;61:1261-1264.
Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264-71.
Giuliano JD, Zimmerman A, Walkup JT, Singer HS. Prevalence of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection by history in a consecutive series of community referred children evaluated for tics. Ann Neurol 1998; 44: 556.
Cardona F, Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 2001; 138: 71-5.
Pichichero ME. PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci. https://www.uptodate.com/contents/pandas-pediatric-autoimmune-neuropsychiatric-disorder-associated-with-group-a-streptococci (Son erişim: 06/06/2021)
Tucker DM, Leckman JF, Scahill L, et al. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad C hild Adolesc Psychiatry 1996; 35: 1684-91.
Singer HS, Hong JJ, Yoon DY, Williams PN. Serum auto-antibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005; 65: 1701-7.
Nicolson R, Swedo SE, Lenane M, et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry 2000; 39: 1313-5.
Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995; 34: 307-11.
Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999; 354: 1153-8.
Murphy TK, Goodman WK, Fudge MW, et al. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry 1997; 154: 402-7.
Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997; 154: 110-2.
Swedo SE, Leonard HL, Rapoport JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics 2004; 113: 907-11.
Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002; 156: 356-61.
Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004; 113: 883.
Snider LA, Swedo SE. Pediatric obsessive-compulsive disorder. JAMA 2000; 284: 3104-6.
Snider LA, Seligman LD, Ketchen BR, et al. Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002; 110: 331-6.
Dale RC, Heyman I, Giovannoni G, Church AW. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry 2005; 187: 314-9.
Williams, K.A., Swedo, S.E., Post-infectious autoimmune disorders: Sydenham’s chorea, PANDAS and beyond. Brain Research (2014), http://dx.doi.org/10.1016/j.brainres.2014.09.071
Hermetter C, Fazekas F, Hochmeister S. Systematic Review: Syndromes, Early Diag-nosis, and Treatment in Autoimmune Encephalitis. Front Neurol 2018; 9: 706.
Lee KW, Liou LM, Wu MN. Fulminant course in a patient with anti-N-methyl-D-aspartate receptor encephalitis with bilateral ovarian teratomas: A case report and literature review. Medicine (Baltimore. 2018;97:e0339.
Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Ne-urology 2014;82:556–63.
Bacchi S, Franke K, Wewegama D, Needham E, Patel S, Menon D. Magnetic resonan-ce imaging and positron emission tomography in anti-NMDA receptor encephalitis: A systematic review. J Clin Neurosci 2018;52:54–9.
Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R. Autoimmu-ne encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 2018;76:41–9.
Salt I, Doğan Ak P, Kalyoncu Aslan I, Özgenç Biçer Çİ, Gözke E. Tam Düzelme İzlenen Bir Anti-NMDA Reseptör Ensefaliti Olgusu. Bosphorus Med J 2021;8(1):47–9.
Sühs KW, Wegner F, Skripuletz T, Trebst C, Tayeb SB, Raab P, et al. Heterogeneity of clinical features and corresponding antibodies in seven patients with anti-NMDA re-ceptor encephalitis. Exp Ther Med 2015;10:1283–92
Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L, et al. Late-onset anti-NMDA receptor encephalitis. Neurology 2013;81:1058–63.
Dale RC, Church AJ, Surtees RA, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain. 2004;127(pt 1):21-33.
Dale RC, Church AJ, Benton S, et al. Post-streptococcal autoimmune dystonia with isolated bilateral striatal necrosis. Dev Med Child Neurol. 2002;44(7):485-489.
McCall S, Henry JM, Reid AH, Taubenberger JK. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol. 2001;60(7):696-704.
Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11-18.
Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66(5):704-709.
R.C. Dale, V. Merheb, S. Pillai, D. Wang, L. Cantrill, T.K. Murphy, H. Ben-Pazi, S. Varadkar, T.D. Aumann, M.K. Horne, A.J. Church, T. Fath, F. Brilot, Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders, Brain 135 (Pt 11) (2012) 3453–3468.
Shah R, Veerapandiyan A, Winchester S, et al. Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies. Pediatr Neurol. 2011;45(6):412-416.
Dimova PS, Bojinova V, Georgiev D, Milanov I. Acute reversible parkinsonism in Epstein-Barr virus-related encephalitis lethargica-like illness. Mov Disord. 2006;21(4):564-566.
Candler PM, Dale RC. Three cases of central nervous system complications associated with Mycoplasma pneumoniae. Pediatr Neurol. 2004;31(2):133-138.
Misra UK, Kalita J. Spectrum of movement disorders in encephalitis. J Neurol. 2010;257(12):2052-2058.
Wang HS, Kuo MF, Huang SC, Chou ML. Choreoathetosis as an initial sign of relapsing of herpes simplex encephalitis. Pediatr Neurol. 1994;11(4):341-345.
Kullnat MW, Morse RP. Choreoathetosis after herpes simplex encephalitis with basal ganglia involvement on MRI. Pediatrics. 2008;121(4): e1003-1007.
Kaichi Y, Kakeda S, Moriya J, Ohnari N, Saito K, Tanaka Y, Tatsugami F, Date S, Awai K, Korogi Y. Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome. AJNR Am J Neuroradiol. 2014 Jan;35(1):100-5.
